Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Early recurrence of benign meningioma correlates with expression of mini-chromosome maintenance-2 protein

1 Jan 2002

Abstract excerpt

We have investigated the potential utility of monoclonal antibodies against mini-chromosome maintenance-2 protein (Mcm2) in predicting meningioma recurrence. MCM proteins are members of the DNA-binding prereplicative complex and are essential for eukaryotic DNA replication. They are present throughout the cell cycle, but are down-regulated in quiescence and cell differentiation, making them specific markers of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Meningioma and schwannoma management
Share to Neurofibromatosis and Schwannoma Cases
Share to Pituitary Gland Disorders and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11928726
DOI: 10.1080/02688690120114174

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Early recurrence of benign meningioma correlates with expression of mini-chromosome maintenance-2 proteinPMID 11928726Read ↗

Expression of Minichromosome Maintenance MCM6 Protein in Meningiomas is Strongly Correlated With Histologic Grade and Clinical OutcomeSemantic proximity Read ↗

Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumorsSemantic proximity Read ↗

Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumorsSemantic proximity Read ↗

Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma.Semantic proximity Read ↗

Predictors of early recurrence in meningiomaSemantic proximity Read ↗

NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas.Semantic proximity Read ↗

Clonal origin of recurrent meningiomas.Semantic proximity Read ↗

Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomasSemantic proximity Read ↗

Mitotic Index is an Independent Predictor of Recurrence‐Free Survival in MeningiomaSemantic proximity Read ↗

Molecular Biological Determinations of Meningioma Progression and RecurrenceSemantic proximity Read ↗

Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA ProfilingSemantic proximity Read ↗

The Cytogenetic Relationship between Primary and Recurrent Meningiomas Points to the Need for New Treatment Strategies in Cases at High Risk of RelapseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.